GSA CAPITAL PARTNERS LLP

Position in LLY — ELI LILLY & Co

CIK 1362033 LONDON, X0

Position in LLY

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,289,387

-$286,179 QoQ

Shares Held

1,075

-37.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#2,900

of 4,605 holders

Holding Since

Sep 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $7,172,969 across 8 Drug Manufacturers - General names. LLY ranks #2 (18.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	28,898	$1,665,102
2	LLY	ELI LILLY & Co This page	1,075	$1,289,387
3	GILD	Gilead Sciences, Inc.	9,877	$1,247,860
4	AMGN	Amgen Inc	2,641	$956,358
5	GRFS	Grifols SA	101,833	$720,977
6	SNY	Sanofi	12,660	$540,075
7	NVS	Novartis AG	2,762	$432,860
8	MRK	Merck & Co., Inc.	2,493	$320,350

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,289,387	1,075	-37.2%	Shares	Sole	2026-08-06
2026-03-31	$1,575,566	1,713	+76.1%	Shares	Sole	2026-05-08
2025-12-31	$1,045,663	973	-24.7%	Shares	Sole	2026-02-06
2025-09-30	$985,796	1,292	-61.9%	Shares	Sole	2025-11-07
2025-06-30	$2,641,047	3,388	+64.0%	Shares	Sole	2025-07-22
2024-12-31	$1,594,952	2,066	+202.0%	Shares	Sole	2025-02-07
2024-09-30	$605,982	684	-86.4%	Shares	Sole	2024-11-05
2023-09-30	$2,709,283	5,044	+197.9%	Shares	Sole	2023-11-15
2023-06-30	$793,983	1,693	+134.2%	Shares	Sole	2023-08-14
2022-12-31	$264,502	723	-76.4%	Shares	Sole	2023-02-13
2022-06-30	$995,061	3,069	-48.7%	Shares	Sole	2022-08-09
2022-03-31	$1,713,351	5,983	+307.6%	Shares	Sole	2022-05-11
2021-12-31	$405,490	1,468	-25.9%	Shares	Sole	2022-02-14
2021-09-30	$457,941	1,982	+62.3%	Shares	Sole	2021-11-12
2020-12-31	$206,153	1,221	-59.4%	Shares	Sole	2021-02-03
2020-09-30	$445,244	3,008	—	Shares	Sole	2020-11-06
No filing history on record for this holder in this stock.